TLDR Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.
The study discussed disorders in male children linked to insufficient androgen action, focusing on the roles of testosterone and dihydrotestosterone (DHT) in virilization. It highlighted that mutations in the 5α-reductase type 2 (5αR-2) gene or androgen receptor (AR) gene, as well as environmental endocrine disruptors, could impair androgen action, leading to conditions like hypospadias, cryptorchidism, and micropenis. The research emphasized the need to consider environmental chemicals as potential disruptors of normal male sexual differentiation, alongside natural genetic mutations.
237 citations,
December 2001 in “Urology” Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.
32 citations,
April 1999 in “Expert Opinion on Investigational Drugs” Finasteride effectively treats male hair loss, improving growth and density.
50 citations,
February 2013 in “Annals of Clinical Biochemistry” Understanding how DHT works is important for diagnosing and treating hormone-related disorders.
11 citations,
August 2020 in “Diabetes” Testosterone helps human pancreatic cells increase insulin release.
5 citations,
January 2001 in “Advances in protein chemistry” 5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.
21 citations,
January 2020 in “General and Comparative Endocrinology” Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.
